Annual Cash & Cash Equivalents
$2.35 B
+$772.52 M+48.88%
31 December 2022
Summary:
Horizon Therapeutics Public Limited annual cash & cash equivalents is currently $2.35 billion, with the most recent change of +$772.52 million (+48.88%) on 31 December 2022. During the last 3 years, it has risen by +$772.52 million (+48.88%).HZNP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.46 B
+$153.00 M+6.62%
30 June 2023
Summary:
Horizon Therapeutics Public Limited quarterly cash and cash equivalents is currently $2.46 billion, with the most recent change of +$153.00 million (+6.62%) on 30 June 2023.HZNP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HZNP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +48.9% | +56.0% |
| 5 y5 years | +118.6% | +129.0% |
HZNP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | at high |
Horizon Therapeutics Public Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $2.46 B(+6.6%) |
| Mar 2023 | - | $2.31 B(-1.8%) |
| Dec 2022 | $2.35 B(+48.9%) | $2.35 B(+10.4%) |
| Sept 2022 | - | $2.13 B(+12.6%) |
| June 2022 | - | $1.89 B(+15.2%) |
| Mar 2022 | - | $1.64 B(+4.0%) |
| Dec 2021 | $1.58 B(-24.0%) | $1.58 B(+47.9%) |
| Sept 2021 | - | $1.07 B(+31.5%) |
| June 2021 | - | $812.32 M(+0.1%) |
| Mar 2021 | - | $811.61 M(-61.0%) |
| Dec 2020 | $2.08 B(+93.2%) | $2.08 B(+20.5%) |
| Sept 2020 | - | $1.73 B(+140.3%) |
| June 2020 | - | $718.06 M(-4.8%) |
| Mar 2020 | - | $754.64 M(-29.9%) |
| Dec 2019 | $1.08 B(+12.3%) | $1.08 B(+21.8%) |
| Sept 2019 | - | $883.96 M(+2.1%) |
| June 2019 | - | $866.00 M(-16.2%) |
| Mar 2019 | - | $1.03 B(+7.7%) |
| Dec 2018 | $958.71 M(+27.6%) | $958.71 M(+18.8%) |
| Sept 2018 | - | $807.05 M(+13.6%) |
| June 2018 | - | $710.21 M(+5.3%) |
| Mar 2018 | - | $674.33 M(-10.3%) |
| Dec 2017 | $751.37 M(+47.6%) | $751.37 M(+20.2%) |
| Sept 2017 | - | $624.96 M(+12.8%) |
| June 2017 | - | $554.27 M(-8.1%) |
| Mar 2017 | - | $603.36 M(+18.5%) |
| Dec 2016 | $509.06 M | $509.06 M(-7.3%) |
| Sept 2016 | - | $549.30 M(+29.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $424.52 M(+10.0%) |
| Mar 2016 | - | $385.85 M(-55.1%) |
| Dec 2015 | $859.62 M(+292.9%) | $859.62 M(+25.6%) |
| Sept 2015 | - | $684.29 M(+2.6%) |
| June 2015 | - | $667.06 M(+22.6%) |
| Mar 2015 | - | $544.21 M(+148.7%) |
| Dec 2014 | $218.81 M(+171.9%) | $218.81 M(-12.0%) |
| Sept 2014 | - | $248.78 M(+93.1%) |
| June 2014 | - | $128.85 M(+24.6%) |
| Mar 2014 | - | $103.37 M(+28.4%) |
| Dec 2013 | $80.48 M(-22.7%) | $80.48 M(+37.2%) |
| Sept 2013 | - | $58.65 M(-15.4%) |
| June 2013 | - | $69.34 M(-14.5%) |
| Mar 2013 | - | $81.08 M(-22.1%) |
| Dec 2012 | $104.09 M(+479.4%) | $104.09 M(-14.2%) |
| Sept 2012 | - | $121.33 M(+91.2%) |
| June 2012 | - | $63.46 M(-21.0%) |
| Mar 2012 | - | $80.35 M(+347.2%) |
| Dec 2011 | $17.97 M(+233.7%) | $17.97 M(-45.6%) |
| Sept 2011 | - | $33.00 M(+471.7%) |
| June 2011 | - | $5.77 M(+125.8%) |
| Mar 2011 | - | $2.56 M(-52.5%) |
| Dec 2010 | $5.38 M(-24.8%) | $5.38 M(-62.1%) |
| Sept 2010 | - | $14.20 M(+7.0%) |
| June 2010 | - | $13.27 M(+550.6%) |
| Mar 2010 | - | $2.04 M(-71.5%) |
| Dec 2009 | $7.16 M(-49.1%) | $7.16 M |
| Dec 2008 | $14.07 M | - |
FAQ
- What is Horizon Therapeutics Public Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Horizon Therapeutics Public Limited?
What is Horizon Therapeutics Public Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of HZNP is $2.35 B
What is the all time high annual cash & cash equivalents for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual cash & cash equivalents is $2.35 B
What is Horizon Therapeutics Public Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HZNP is $2.46 B
What is the all time high quarterly cash and cash equivalents for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly cash and cash equivalents is $2.46 B